跳至主導覽 跳至搜尋 跳過主要內容

Network pharmacology implicates traditional Chinese medicine in regulating systemic homeostasis to benefit Alzheimer's disease

研究成果: 期刊稿件 › 文獻綜述 › 同儕審查

9 引文 斯高帕斯(Scopus)

摘要

Traditional Chinese medicine (TCM) has the characteristics of multi-component, multi-target, and biological systems coordination, which meet the criteria of the network pharmacological application. Therefore, using network pharmacology to discover the relationship between TCM, diseases, and cellular responses is easily achievable. Aging-induced imbalanced homeostasis is a risk factor for Alzheimer's disease (AD), a neuronal disease regulated by multiple genes. Meta-analysis of TCM in metabolic regulation to improve symptoms of AD helps understand the pharmacological effects. The drug targets of TCM can be investigated using a holistic network pharmacology approach to find potential modulators involved in AD-related metabolic pathways. Based on the theoretical prediction of TCM for AD, experimental validation is needed to develop pure compounds for specific treatments.

原文英語
頁(從 - 到)120-130
頁數11
期刊Tzu Chi Medical Journal
卷35
發行號2
DOIs
出版品狀態Published - 2023

指紋

深入研究「Network pharmacology implicates traditional Chinese medicine in regulating systemic homeostasis to benefit Alzheimer's disease」主題。共同形成了獨特的指紋。

引用此